RecruitingNCT05227924

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty


Sponsor

Dedienne Sante S.A.S.

Enrollment

747 participants

Start Date

Sep 21, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Total hip arthroplasty (primary or revision) for people with avascular necrosis of the femoral head, degenerative hip joint disease, and other related conditions. The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETotal hip arthroplasty (primary or revision)

Total hip arthroplasty with at least one medical device from the SYMBOL range


Locations(9)

Hôpital Privé de la Châtaigneraie

Beaumont, France

CH de Marmande - CHIC

Marmande, France

Hôpital Privé du Grand Narbonne

Montredon-des-Corbières, France

Polyclinique Grand Sud

Nîmes, France

Clinique Mutualiste Catalane

Perpignan, France

CH de Péronne

Péronne, France

Clinique Mutualiste

Saint-Etienne, France

Hôpital d'Instruction des Armées Saint-Anne

Toulon, France

Hôpital Robert Schuman - UNEOS

Vantoux, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05227924


Related Trials